Clinical characteristics of 82 death cases with COVID-19
暂无分享,去创建一个
Hengcheng Zhu | Xiongfei Wu | Jun Wang | Ling Gao | Bicheng Zhang | Bo Zhu | Lilei Yu | Q. Song | K. Hu | Bicheng Zhang | Xiaoyang Zhou | Xiaoyang Zhou | Ling Gao | Yanru Qiu | Fan Feng | Jia Feng | Qibin Song | Yifan Jia | Ke Hu | Jiasheng Liu | Zaiming Liu | Shihong Wang | Yiping Gong | Chenliang Zhou | Ting Zhu | Yanxiang Cheng | Zhichao Liu | Hongping Deng | Fenghua Tao | Yijun Ren | Biheng Cheng | Zhixin Huang | Zhangfan Mao | Jun Wang | Yiping Gong | Jiasheng Liu | Yijun Ren | Zhixin Huang | Z. Mao | Shihong Wang | B. Zhu | Jia Feng | Hongping Deng | Yanxiang Cheng | Yifan Jia | Hengcheng Zhu | T. Zhu | Zhichao Liu | Chenliang Zhou | Yanru Qiu | B. Cheng | Xiongfei Wu | Bi-cheng Zhang | Fan Feng | Lilei Yu | Zaiming Liu | Fenghua Tao | Biheng Cheng | Lilei Yu
[1] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[2] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[3] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[4] J. Sung,et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.
[5] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[6] M. Dixit,et al. Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting , 2010, Pharmaceuticals.
[7] W. Liang,et al. Clinical characteristics of 2019 novel coronavirus infection in China , 2020, medRxiv.
[8] Qibo Zhang,et al. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile , 2018, Cytokine.
[9] Christian Drosten,et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells , 2020, bioRxiv.
[10] E. Klein,et al. Risk of Acute Kidney Injury Associated With Medication Administration in the Emergency Department. , 2020, The Journal of emergency medicine.
[11] Jue Fan,et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection , 2020, bioRxiv.
[12] S. Seth,et al. NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. , 2015, Indian heart journal.
[13] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[14] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[15] Ruchong Chen,et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.
[16] Christian Drosten,et al. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.
[17] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[18] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[19] Q. Pham,et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam , 2020, The New England journal of medicine.
[20] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[21] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.